Judges Scientific (GB:JDG) has released an update.
Judges Scientific, a group acquiring firms in the scientific instrument sector, reports a subdued first half of 2024 with a 4% drop in organic order intake and a 3% decline in organic revenue compared to the previous year. The company completed two acquisitions despite challenging market conditions, which led to varied performance across regions, with significant downturns in China/Hong Kong and North America. While the second half is expected to improve, overall earnings per share are projected to be 5-10% below market expectations, though the company maintains a healthy order book and solid financial position.
For further insights into GB:JDG stock, check out TipRanks’ Stock Analysis page.
